Raymond James Increases PT on Dyne Therapeutics Stock from $31 to $35, Maintains Buy Rating
Dyne Therapeutics, Inc. (NASDAQ:DYN) is one of the 14 Best Small Cap Stocks to Buy Right Now. On August 25, Raymond James increased the price target on Dyne Therapeutics, Inc. (NASDAQ:DYN) stock from 35, maintaining its Buy rating. Martin Auster from Raymond James upgraded the price target on DYN as he remains optimistic on the upcoming DYNE-251 registrational cohort readout expected in late 2025. Auster sees potential in the upcoming investigational exon-skipping therapy for Duchenne Muscular Dys ...